MBP and myeloid sarcoma: Thus, Lang and colleagues demonstrated that the Hy.2E11 TCR from an MS patient cross-recognized a DRB1*1501-restricted MBP peptide and a DRB5*0101 restricted EBV DNA polymerase peptide [183].